Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. IMCD N.V.
  6. News
  7. Summary
    IMCD   NL0010801007


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

IMCD N : Borealis appoints IMCD as Bormed healthcare portfolio distributor

07/13/2021 | 03:59am EDT
  • Distribution agreement to take effect as of 1 October 2021
  • New agreement applies to Bormedportfolio of innovative polyolefin grades for healthcare
  • Complementary Borealis and IMCD product portfolios to enable even more choice in polymers

Borealisannounces that it has selected IMCD, a global leader in the distribution of specialty chemicals and ingredients, as its new European distributor of its dedicated grade range of Bormed™ polyolefins for healthcare. The distribution agreement covers most of Europe (with the exception of Switzerland and the South-Eastern countries1) and takes effect as of 1 October 2021. It applies to Bormed products used in pharmaceutical packaging, medical and diagnostic devices.

As a distributor with strong presence in medical and healthcare applications, IMCD is the ideal partner for Borealis customers in Europe thanks to its broad technical expertise and dedicated medical application team. The extensive IMCD polymers range complements the Borealis Bormed portfolio, opening a range of new possibilities. IMCD was selected from a broad field of potential distributors following a rigorous screening process.

'We are pleased to have found in IMCD a partner sharing the core Bormed values of service, commitment and conformance,' said John Webster, Borealis Head of Sales Advanced Products. 'What also unites us is our dedication to providing best-in-class service to all of our healthcare customers, both direct and indirect, by way of more intensive and efficient value chain collaboration. We are confident that this new agreement will significantly boost our presence in this increasingly important sector.'

In line with its commitment to service as the foundation of successful industry co-operation, Borealis and IMCD will together ensure a seamless distribution transition for their customers, who can continue to count on security of supply as well as the ready assistance of experienced technical and sales teams.

Olivier Champault, Director of IMCD Business Group Advanced Materials 'We are delighted to be selected as the new partner for Borealis in their healthcare business. This partnership is completely aligned with our strategy to further expand and strengthen our presence in the medical and healthcare segment in Europe. With our dedicated experts in medical and healthcare applications, our well-establish distribution network, and our board product offering, we are fully committed to accelerate growth and to support our customers in their developments and innovations.'

Question regarding the commercial activities, please contact us here!


IMCD NV published this content on 13 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 July 2021 07:58:03 UTC.

ę Publicnow 2021
All news about IMCD N.V.
09/23IMCD PRESENTS POWERING TOMORROW : new insights for the Lubricants and Energy landscape, an..
09/20IMCD N.V.(ENXTAM : IMCD) added to S&P Global 1200
09/20IMCD N.V.(ENXTAM : IMCD) added to S&P EUROPE 350
09/20IMCD N.V.(ENXTAM : IMCD) added to S&P EUROPE 350 - Industrials
09/20IMCD N.V.(ENXTAM : IMCD) added to S&P EUROPE 350 - Capital Goods (Industry Group)
09/20IMCD N.V.(ENXTAM : IMCD) added to S&P International 700
09/09IMCD N : presents Advanced Materials for a Sustainable Tomorrow
09/01IMCD N : Culinary Technical Expertise
08/31IMCD N : 2021 AGM draft minutes
08/09ANALYST RECOMMENDATIONS : AMC, AMD, Greggs, Roku, Tesla...
More news
Analyst Recommendations on IMCD N.V.
More recommendations
Sales 2021 3 328 M 3 901 M 3 901 M
Net income 2021 196 M 230 M 230 M
Net Debt 2021 726 M 851 M 851 M
P/E ratio 2021 49,1x
Yield 2021 0,79%
Capitalization 9 573 M 11 210 M 11 220 M
EV / Sales 2021 3,09x
EV / Sales 2022 2,86x
Nbr of Employees -
Free-Float 98,0%
Chart IMCD N.V.
Duration : Period :
IMCD N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IMCD N.V.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 168,25 €
Average target price 151,90 €
Spread / Average Target -9,72%
EPS Revisions
Managers and Directors
Pieter C. J. van der Slikke Chief Executive Officer
Hans Kooijmans Chief Financial Officer
Janus Smalbraak Chairman-Supervisory Board
Arjan J. T. Kaaks Vice Chairman-Supervisory Board
Stephan Ronald Nanninga Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
IMCD N.V.61.39%11 210
ECOLAB INC.3.42%64 018
SIKA AG33.13%49 312
GIVAUDAN SA17.21%43 598
HENKEL AG & CO. KGAA-14.11%38 534